Insights

US Leadership Aurobindo Pharma is the largest generic pharmaceutical company in the United States, with US revenue contributing a significant portion of overall sales. This suggests strong opportunities for partnerships and supply agreements in the US market, particularly for high-demand generics and specialty APIs.

US Novel Launch The launch of Adquey, a novel PDE4 inhibitor for atopic dermatitis in the US, via Acrotech indicates capability in bringing new drugs to the US market. This positions the company for potential collaboration on dermatology products or pipeline co-development and licensing in related therapeutic areas.

Strategic Acquisitions Recent acquisition of A1 Biochem Labs LLC strengthens manufacturing and R&D capabilities and expands the geographic footprint. This can be leveraged to offer contract manufacturing, formulation development, or API supply optimization to customers seeking scale, resilience, and regional diversification.

Regulatory Footprint With over 30 manufacturing facilities approved by major global regulators (USFDA, UK MHRA, PMDA, WHO, ANVISA, etc.), Aurobindo offers a robust, compliant production base suitable for high-volume production, complex generics, and sensitive APIs—an attractive value proposition for risk-averse buyers seeking reliable supply.

Pipeline and Diversification A diversified portfolio across CNS, ARV, CVS, antibiotics, GI, anti-diabetics, oncology, and dermatology, along with strong R&D, suggests cross-sell opportunities to large healthcare providers, distributors, and private-label partners looking to broaden their generics and specialty drug offerings in multiple markets.

Similar companies to AUROBINDO PHARMA LTD

AUROBINDO PHARMA LTD Tech Stack

AUROBINDO PHARMA LTD uses 8 technology products and services including Power BI, jsDelivr, Joomla, and more. Explore AUROBINDO PHARMA LTD's tech stack below.

  • Business Intelligence
  • jsDelivr
    Content Delivery Network
  • Content Management System
  • Content Management System
  • Cookie Notice
    Cookie Compliance
  • Office Suites
  • Ubuntu
    Operating Systems
  • Windows Server
    Operating Systems

Media & News

AUROBINDO PHARMA LTD's Email Address Formats

AUROBINDO PHARMA LTD uses at least 4 email formats:
AUROBINDO PHARMA LTD Email FormatsExamplePercentage
First.Last@aurobindo.comJohn.Doe@aurobindo.com
92%
FLast@aurobindo.comJDoe@aurobindo.com
5%
First_Last@aurobindo.comJohn_Doe@aurobindo.com
2%
First@aurobindo.comJohn@aurobindo.com
1%

Frequently Asked Questions

What is AUROBINDO PHARMA LTD's official website and social media links?

Minus sign iconPlus sign icon
AUROBINDO PHARMA LTD's official website is aurobindo.com and has social profiles on LinkedIn.

How much revenue does AUROBINDO PHARMA LTD generate?

Minus sign iconPlus sign icon
As of October 2026, AUROBINDO PHARMA LTD's annual revenue is estimated to be $1B - $10B.

What is AUROBINDO PHARMA LTD's SIC code and NAICS code?

Minus sign iconPlus sign icon
AUROBINDO PHARMA LTD's SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances and NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does AUROBINDO PHARMA LTD have currently?

Minus sign iconPlus sign icon
As of October 2026, AUROBINDO PHARMA LTD has approximately 15K employees across 6 continents, including Asia, North America and Europe. Key team members include Ceo-Europe: V. M. M., Chief Executive Officer: R. A. and Chief Executive Officer: A. R. Explore AUROBINDO PHARMA LTD's employee directory with LeadIQ.

What industry does AUROBINDO PHARMA LTD belong to?

Minus sign iconPlus sign icon
AUROBINDO PHARMA LTD operates in the Pharmaceutical Manufacturing industry.

What technology does AUROBINDO PHARMA LTD use?

Minus sign iconPlus sign icon
AUROBINDO PHARMA LTD's tech stack includes Power BI, jsDelivr, Joomla, WordPress, Cookie Notice, Office 365, Ubuntu and Windows Server.

What is AUROBINDO PHARMA LTD's email format?

Minus sign iconPlus sign icon
AUROBINDO PHARMA LTD's email format typically follows the pattern of First.Last@aurobindo.com. Find more AUROBINDO PHARMA LTD email formats with LeadIQ.

When was AUROBINDO PHARMA LTD founded?

Minus sign iconPlus sign icon
AUROBINDO PHARMA LTD was founded in 1986.
AUROBINDO PHARMA LTD logo

AUROBINDO PHARMA LTD

Pharmaceutical ManufacturingTelangana, India10001+ Employees

Aurobindo Pharma Limited is an integrated global pharmaceutical company headquartered in Hyderabad, Telangana, India. It develops, manufactures, and markets a broad range of generic medicines, branded specialty drugs, and active pharmaceutical ingredients for markets in more than 150 countries. The company is a major player in the generic space, with a substantial footprint in the United States where it is the largest generic pharmaceutical company, and a presence in Europe where it ranks in the top 10 in several countries. Its manufacturing and packaging network comprises multiple facilities approved by major regulators, including USFDA, UK MHRA, EDQM, PMDA, WHO, Health Canada, MCC, and ANVISA. The portfolio spans eight therapeutic areas—CNS, antiretrovirals, cardiovascular, antibiotics, gastroenterology, anti-diabetics, oncology, and dermatology—and is supported by a robust research and development framework. In June 2026, Aurobindo announced plans to develop a major biologics contract manufacturing facility in Telangana, with MSD Pharma named as anchor client, marking an expansion into biologics manufacturing.

Section iconCompany Overview

SIC Code
2835 - In Vitro and In Vivo Diagnostic Substances
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1986
Employees
10001+

Section iconFunding & Financials

  • $1B - $10B

    AUROBINDO PHARMA LTD's revenue is estimated to be in the range of $1B - $10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.